Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Calcium430 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10155 | 31465774 | Biochem Pharmacol | Functions of aryl hydrocarbon receptor (AHR) and CD38 in NAD metabolism and nonalcoholic steatohepatitis (NASH). | 2019 | Details |
| A10174 | 31454158 | Mol Nutr Food Res | Tomatidine Reduces Palmitate-Induced Lipid Accumulation by Activating AMPK via Vitamin D Receptor-Mediated Signaling in Human HepG2 Hepatocytes. | 2019 | Details |
| A10185 | 31445019 | Biochem Pharmacol | M3 muscarinic receptor activation reduces hepatocyte lipid accumulation via CaMKKβ/AMPK pathway. | 2019 | Details |
| A10189 | 31442319 | Hepatology | Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation. | 2020 | Details |
| A10218 | 31426291 | Int J Mol Sci | Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease. | 2019 | Details |
| A10256 | 31409057 | Cells | iPla2β Deficiency Suppresses Hepatic ER UPR, Fxr, and Phospholipids in Mice Fed with MCD Diet, Resulting in Exacerbated Hepatic Bile Acids and Biliary Cell Proliferation. | 2019 | Details |
| A10280 | 31401389 | Cell Calcium | Deranged hepatocyte intracellular Ca2+ homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma. | 2019 | Details |
| A10506 | 31309533 | FEBS Lett | Chronic exposure to Pb2+ perturbs ChREBP transactivation and coerces hepatic dyslipidemia. | 2019 | Details |
| A10594 | 31278269 | Nat Commun | Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy. | 2019 | Details |
| A10631 | 31262497 | Am J Cardiol | Nonalcoholic Fatty Liver Disease Is Associated With Arterial Distensibility and Carotid Intima-Media Thickness: (from the Multi-Ethnic Study of Atherosclerosis). | 2019 | Details |
| A10636 | 31260143 | J Gastroenterol Hepatol | Genetic and lifestyle risk factors for advanced liver disease among men and women. | 2019 | Details |
| A10864 | 32953568 | J Tradit Complement Med | Calcium supplementation shows a hepatoprotective effect against high-fat diet by regulating oxidative-induced inflammatory response and lipogenesis activity in male rats. | 2019 | Details |
| A10879 | 31143330 | Pan Afr Med J | Non alcoholic fatty liver disease in a young male with celiac disease. | 2019 | Details |
| A10966 | 31100460 | Clin Gastroenterol Hepatol | Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes. | 2019 | Details |
| A10985 | 31090336 | Zhongguo Zhong Yao Za Zhi | [Analysis on mechanisms and medication rules of herbal prescriptions for nonalcoholic fatty liver disease based on methods of data mining and biological information]. | 2019 | Details |
| A10992 | 31089384 | Iran J Pharm Res | Reduction of Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver by Vitamin D and Calcium Co-Supplementation: A Double Blind Randomized Controlled Clinical Trial. | 2019 | Details |
| A11047 | 31069793 | J Cell Physiol | S100A16, a novel lipogenesis promoting factor in livers of mice and hepatocytes in vitro. | 2019 | Details |
| A11095 | 31044438 | Hepatology | NOD-like receptor C4 Inflammasome Regulates the Growth of Colon Cancer Liver Metastasis in NAFLD. | 2019 | Details |
| A11242 | 30977830 | J Clin Endocrinol Metab | Diet-Dependent Acid Load-The Missing Link Between an Animal Protein-Rich Diet and Nonalcoholic Fatty Liver Disease? | 2019 | Details |
| A11261 | 30970434 | Gut Liver | Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11544 | 30850262 | Trends Endocrinol Metab | Calcium Signaling As a Therapeutic Target for Liver Steatosis. | 2019 | Details |
| A11550 | 30847862 | J Endocrinol Invest | Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes. | 2019 | Details |
| A11578 | 30832722 | Trials | Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial. | 2019 | Details |
| A11584 | 30829592 | Georgian Med News | EVALUATION OF TREATMENT EFFICACY IN PATIENTS WITH NON-ALCOHOLIC-STEATOHEPATITIS AND HETEROZYGOTIC FAMILIAL HYPERCHOLESTEROLEMIA. | 2019 | Details |
| A11601 | 30824190 | Biochem Biophys Res Commun | NLRC4 inflammasome activation regulated by TNF-α promotes inflammatory responses in nonalcoholic fatty liver disease. | 2019 | Details |
| A11628 | 32670671 | Liver Res | Endoplasmic reticulum stress and liver diseases. | 2019 | Details |
| A11654 | 30803094 | Microcirculation | Multi-domain analysis of microvascular flow motion dynamics in NAFLD. | 2019 | Details |
| A11726 | 30774848 | Int J Prev Med | Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease: A Systematic Review of Randomized Controlled Clinical Trials. | 2019 | Details |
| A11734 | 30772256 | Mol Metab | Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice. | 2019 | Details |
| A11799 | 30735855 | Biochim Biophys Acta Mol Cell Biol Lipids | Group VIA phospholipase A2 deficiency in mice chronically fed with high-fat-diet attenuates hepatic steatosis by correcting a defect of phospholipid remodeling. | 2019 | Details |
| A11800 | 30735854 | Biochim Biophys Acta Mol Cell Biol Lipids | iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes. | 2019 | Details |
| A11819 | 30721562 | Liver Int | MicroRNA-30b regulates insulin sensitivity by targeting SERCA2b in non-alcoholic fatty liver disease. | 2019 | Details |
| A12050 | 30623792 | Biomaterials | Intravenous sustained-release nifedipine ameliorates nonalcoholic fatty liver disease by restoring autophagic clearance. | 2019 | Details |
| A12150 | 30581002 | Biochem Biophys Res Commun | Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-β1. | 2018 | Details |
| A12162 | 30577497 | Int J Mol Sci | Olive Oil, Palm Oil, and Hybrid Palm Oil Distinctly Modulate Liver Transcriptome and Induce NAFLD in Mice Fed a High-Fat Diet. | 2018 | Details |
| A12271 | 30539788 | Cell Mol Gastroenterol Hepatol | Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12286 | 30529590 | J Hepatol | Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis. | 2018 | Details |
| A12326 | 30515395 | Biomed Res Int | Oxidative Stress and Nonalcoholic Fatty Liver Disease in Hemodialysis Patients. | 2018 | Details |
| A12360 | 30487332 | Clin Calcium | [Secondary osteoporosis. Bone disease in liver cirrhosis.] | 2019 | Details |
| A12397 | 30472683 | Gut | Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study. | 2018 | Details |
| A12425 | 30458883 | J Transl Med | Matrine attenuates endoplasmic reticulum stress and mitochondrion dysfunction in nonalcoholic fatty liver disease by regulating SERCA pathway. | 2018 | Details |
| A12605 | 30367044 | Nat Commun | Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling. | 2018 | Details |
| A12683 | 30328321 | Yonsei Med J | S100A4 Gene is Crucial for Methionine-Choline-Deficient Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice. | 2018 | Details |
| A12732 | 30312631 | Toxicol Appl Pharmacol | Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: Implications for nonalcoholic steatohepatitis and diabetes. | 2018 | Details |
| A12804 | 30279702 | Front Genet | Analysis of Time-Series Gene Expression Data to Explore Mechanisms of Chemical-Induced Hepatic Steatosis Toxicity. | 2018 | Details |
| A12862 | 30250893 | Mol Cell Oncol | Cisd2 haploinsufficiency: A driving force for hepatocellular carcinoma. | 2018 | Details |
| A12982 | 30197519 | Ther Clin Risk Manag | Epicardial adipose tissue volume is associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population. | 2018 | Details |
| A13140 | 30120405 | Pediatr Res | Hepatic fat content and bone mineral density in children with overweight/obesity. | 2018 | Details |
| A13189 | 30094399 | Hepatol Commun | Association of Hepatic Steatosis With Subclinical Atherosclerosis: Systematic Review and Meta-Analysis. | 2018 | Details |
| A13257 | 30060948 | Biochem Biophys Res Commun | Saxagliptin regulates M1/M2 macrophage polarization via CaMKKβ/AMPK pathway to attenuate NAFLD. | 2018 | Details |
| A13343 | 30023358 | Front Med (Lausanne) | Calcium Signaling in Liver Injury and Regeneration. | 2018 | Details |
| A13359 | 30016459 | J Neuropathol Exp Neurol | Histological Features of Cerebellar Neuropathology in Patients With Alcoholic and Nonalcoholic Steatohepatitis. | 2018 | Details |
| A13512 | 29940269 | J Hepatol | Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. | 2018 | Details |
| A13807 | 29746898 | Biochim Biophys Acta Mol Cell Res | Two-pore channels and disease. | 2018 | Details |
| A13962 | 29670844 | Adv Pharm Bull | The Eeffect of Metformin Combined with Calcium-Vitamin D3 Against Diet-Induced Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14057 | 29607802 | Public Health Nutr | Intakes of magnesium, calcium and risk of fatty liver disease and prediabetes. | 2018 | Details |
| A14093 | 29590715 | Acta Clin Croat | Nutritional Status and Nutrition Quality in Patients with Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A14107 | 29579601 | Int J Cardiol | Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis. | 2018 | Details |
| A14167 | 29555681 | J Biol Chem | Patatin-like phospholipase domain–containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets. | 2018 | Details |
| A14301 | 29474931 | Biochim Biophys Acta Mol Cell Biol Lipids | Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model. | 2018 | Details |
| A14304 | 29472495 | Drug Metab Dispos | Apixaban and Rosuvas--tatin Pharmacokinetics in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14420 | 29414781 | J Biol Chem | Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway. | 2018 | Details |
| A14476 | 29395967 | Growth Horm IGF Res | Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects. | 2018 | Details |
| A14494 | 29382663 | Diabetes | Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis. | 2018 | Details |
| A14613 | 29323715 | J Cell Physiol | Alleviation of palmitic acid-induced endoplasmic reticulum stress by augmenter of liver regeneration through IP3R-controlled Ca2+ release. | 2018 | Details |
| A14660 | 29303514 | Exp Mol Med | Depletion of S100A4+ stromal cells does not prevent HCC development but reduces the stem cell-like phenotype of the tumors. | 2018 | Details |
| A14662 | 29299797 | Ecotoxicology | Transcriptome assembly and expression profiling of the molecular responses to cadmium toxicity in cerebral ganglia of wolf spider Pardosa pseudoannulata (Araneae: Lycosidae). | 2018 | Details |
| A14836 | 29210656 | Curr Vasc Pharmacol | Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment. | 2018 | Details |
| A14936 | 29166610 | Cell Rep | CISD2 Haploinsufficiency Disrupts Calcium Homeostasis, Causes Nonalcoholic Fatty Liver Disease, and Promotes Hepatocellular Carcinoma. | 2017 | Details |
| A15022 | 29126901 | Biochim Biophys Acta Mol Cell Biol Lipids | Omega-3 polyunsaturated fatty acids protect human hepatoma cells from developing steatosis through FFA4 (GPR120). | 2017 | Details |
| A15209 | 29046367 | Biosci Rep | PKCδ silencing alleviates saturated fatty acid induced ER stress by enhancing SERCA activity. | 2017 | Details |
| A15229 | 29035092 | Crit Rev Food Sci Nutr | Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials. | 2017 | Details |
| A15251 | 29023819 | Hepatology | Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5-trisphosphate receptor. | 2018 | Details |
| A15296 | 28981157 | J Pineal Res | Effects of melatonin on fatty liver disease: The role of NR4A1/DNA-PKcs/p53 pathway, mitochondrial fission, and mitophagy. | 2017 | Details |
| A15323 | 28966992 | Hepatol Commun | Hepatic Inositol 1,4,5 Trisphosphate Receptor Type 1 Mediates Fatty Liver. | 2016 | Details |
| A15333 | 28964324 | Metabolism | Coffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis. | 2017 | Details |
| A15341 | 28956816 | Nutrients | Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis. | 2017 | Details |
| A15370 | 28941732 | Exp Mol Pathol | The adaptor protein alpha-syntrophin is reduced in human non-alcoholic steatohepatitis but is unchanged in hepatocellular carcinoma. | 2017 | Details |
| A15386 | 28935446 | Mitochondrion | Mitochondrial adaptation in steatotic mice. | 2017 | Details |
| A15413 | 28924233 | Sci Rep | Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD. | 2017 | Details |
| A15451 | 28900935 | Adv Exp Med Biol | Metabolic Disorders and Cancer: Hepatocyte Store-Operated Ca2+ Channels in Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15562 | 28842679 | Sci Rep | Olfactory receptor 10J5 responding to α-cedrene regulates hepatic steatosis via the cAMP-PKA pathway. | 2017 | Details |
| A15563 | 28842428 | FASEB J | Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis. | 2017 | Details |
| A15745 | 28731143 | Mol Med Rep | Suppression of hepatic dysfunction in tenascin‑X‑deficient mice fed a high‑fat diet. | 2017 | Details |
| A15779 | 28713156 | Acta Pharmacol Sin | Discovery of a novel calcium-sensitive fluorescent probe for α-ketoglutarate. | 2017 | Details |
| A15818 | 28694658 | World J Gastroenterol | Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease. | 2017 | Details |
| A15841 | 28686633 | PLoS One | Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation. | 2017 | Details |
| A15889 | 28669329 | Curr Vasc Pharmacol | Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension. | 2018 | Details |
| A16147 | 28539530 | Endocr J | Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model. | 2017 | Details |
| A16192 | 28511152 | Wiad Lek | [Pathogenetic substantiation of complex treatment of nonalcoholic steatohepatitis and steatosis in patients with pre-diabetes and type 2 diabetes]. | 2017 | Details |
| A16235 | 28493399 | Echocardiography | Diagnosis of fatty liver by computed tomography coronary artery calcium score. | 2017 | Details |
| A16552 | 28319895 | Redox Biol | Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: An updated mini-review. | 2017 | Details |
| A16588 | 28297775 | Zhonghua Gan Zang Bing Za Zhi | [Effect of calcium-independent phospholipase A(2) inhibitor in reducing hepatocyte lipoapoptosis and improving insulin resistance]. | 2017 | Details |
| A16726 | 28220621 | J Diabetes | Low prevalence of non-alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease. | 2017 | Details |
| A16729 | 28219837 | J Nutr Biochem | Chronic maternal calcium and 25-hydroxyvitamin D deficiency in Wistar rats programs abnormal hepatic gene expression leading to hepatic steatosis in female offspring. | 2017 | Details |
| A16750 | 28211103 | J Neuroendocrinol | Impaired learning and memory in rats induced by a high-fat diet: Involvement with the imbalance of nesfatin-1 abundance and copine 6 expression. | 2017 | Details |
| A16751 | 28210913 | Int Urol Nephrol | Dietary and commercialized fructose: Sweet or sour? | 2017 | Details |
| A16982 | 28064001 | Biochim Biophys Acta Mol Cell Res | Endoplasmic reticulum-mitochondria calcium signaling in hepatic metabolic diseases. | 2017 | Details |
| A17054 | 28025996 | Int J Mol Med | Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice. | 2016 | Details |
| A17101 | 27991906 | Lab Invest | Hepatic stimulator substance inhibits calcium overflow through the mitochondria-associated membrane compartment during nonalcoholic steatohepatitis. | 2016 | Details |